ScholarIQanswers from OpenAlex

Ferroptosis: A New Research Direction of Artemisinin and Its Derivatives in Anti-Cancer Treatment

PaperCitations, authors & open-access status

Ferroptosis: A New Research Direction of Artemisinin and Its Derivatives in Anti-Cancer Treatment is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Ferroptosis: A New Research Direction of Artemisinin and Its Derivatives in Anti-Cancer Treatment have?

ScholarIQcitation count

Ferroptosis: A New Research Direction of Artemisinin and Its Derivatives in Anti-Cancer Treatment has 36 citations in the OpenAlex counts ScholarIQ stores.

When was Ferroptosis: A New Research Direction of Artemisinin and Its Derivatives in Anti-Cancer Treatment published?

ScholarIQyear

Ferroptosis: A New Research Direction of Artemisinin and Its Derivatives in Anti-Cancer Treatment has 2024 year in the ScholarIQ index.

What is the open-access status of Ferroptosis: A New Research Direction of Artemisinin and Its Derivatives in Anti-Cancer Treatment?

ScholarIQoa status

Ferroptosis: A New Research Direction of Artemisinin and Its Derivatives in Anti-Cancer Treatment has closed oa status in the ScholarIQ index.

What is the DOI of Ferroptosis: A New Research Direction of Artemisinin and Its Derivatives in Anti-Cancer Treatment?

ScholarIQdoi

The DOI for Ferroptosis: A New Research Direction of Artemisinin and Its Derivatives in Anti-Cancer Treatment is on the source record.

What is the PMID of Ferroptosis: A New Research Direction of Artemisinin and Its Derivatives in Anti-Cancer Treatment?

ScholarIQpmid

The PMID for Ferroptosis: A New Research Direction of Artemisinin and Its Derivatives in Anti-Cancer Treatment is on the source record.

What is the OpenAlex record for Ferroptosis: A New Research Direction of Artemisinin and Its Derivatives in Anti-Cancer Treatment?

ScholarIQopenalex

The OpenAlex for Ferroptosis: A New Research Direction of Artemisinin and Its Derivatives in Anti-Cancer Treatment is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial